Ivermectin for Malaria Control

描述（由申请人提供）：蚊媒疾病对发展中国家，特别是非洲造成的公共卫生和经济负担是巨大的。疟疾占全球蚊媒疾病发病率和死亡率的最大部分。迫切需要以与传统杀虫剂不同的方式减少蚊子传播疟疾的新型病媒控制工具，包括在蚊子中具有新的分子靶标的工具、向蚊子递送的新模式以及可以靶向通过经杀虫剂处理的蚊帐或室内滞留喷洒未得到良好控制的病媒传播的工具。为了在发展中世界资源有限的环境中发挥最大效力，这些工具还必须能够与现有的疟疾控制干预措施和现有的人类卫生基础设施相结合。我们的广泛假设是，伊维菌素用于非洲村庄的人类驱虫运动，我们已经证明它可以破坏塞内加尔村庄的疟疾寄生虫传播，可以作为这些有前途的新工具之一。伊维菌素是一种口服药物，已经在发展中国家大规模给药，用于控制盘尾丝虫病，疟疾病媒在这些大规模给药后叮咬人类时可以摄入并被这种药物杀死。我们的数据表明，在疟疾流行社区更频繁地使用伊维菌素将导致疟疾寄生虫传播的持续减少。为了实现这一目标，有必要在田间和实验室对伊维菌素对疟疾病媒的作用进行彻底的检查。我们提出了两个具体目标：目标1：在塞内加尔进行野外人群研究伊维菌素摄入野生疟疾病媒的影响。目的2：对伊维菌素对蚊子和疟原虫传播的影响进行实验室和模型研究。 公共卫生相关性：该项目旨在了解药物伊维菌素如何影响非洲疟疾病媒的生存并阻断疟疾寄生虫在非洲的传播。该项目旨在为使用伊维菌素作为一种新的疟疾控制工具奠定科学基础。

DESCRIPTION (provided by applicant): The public health and economic burden imposed by mosquito-borne diseases on the developing world, and especially Africa, is enormous. Malaria accounts for the largest portion of global mosquito-borne disease morbidity and mortality. There is an urgent need for novel vector control tools that reduce malaria transmission by mosquitoes in distinct ways from traditional insecticides, including tools that have new molecular targets in mosquitoes, new modes of delivery to the mosquito, and tools that can target transmission by vectors not well- controlled by insecticide-treated nets or indoor residual spraying. To be maximally effective in resource- constrained environments of the developing world, such tools must also be able to integrate with existing malaria control interventions and existing human health infrastructures. Our broad hypothesis is that ivermectin used in human de-worming campaigns in African villages, and which we have shown can disrupt malaria parasite transmission in Senegalese villages, could serve as one of these promising new tools. Ivermectin is an oral drug, already given by mass administration to humans in the developing world for onchocerciasis control, and malaria vectors can ingest and be killed by this drug when they bite humans after these mass drug administrations. Our data suggests that more frequent administrations of ivermectin in malaria-endemic communities would result in sustained reductions in malaria parasite transmission. To get to this goal, a thorough examination of the ivermectin effects against malaria vectors in the field and laboratory is necessary. We propose two specific aims: Aim 1: Perform field population studies in Senegal on the effects of ivermectin ingested by wild malaria vectors. Aim 2: Perform laboratory and modeling studies on the effects ivermectin may have on mosquitoes and malaria parasite transmission. PUBLIC HEALTH RELEVANCE: This project proposes to understand how the drug ivermectin can affect the survival of African malaria vectors and interrupt malaria parasite transmission in Africa. The project is intended to lay the scientific foundation for using ivermectin as a new malaria control tool.